Clinical Use of Human Hepatocyte Growth Factor in the Early Detection of HELLP Syndrome
作者:
Hideaki Iioka,
期刊:
Gynecologic and Obstetric Investigation
(Karger Available online 1996)
卷期:
Volume 41,
issue 2
页码: 103-105
ISSN:0378-7346
年代: 1996
DOI:10.1159/000292052
出版商: S. Karger AG
关键词: Human hepatocyte growth factor;HELLP syndrome
数据来源: Karger
摘要:
The change in plasma concentration of human hepatocyte growth factor (hHGF) in pregnant women with HELLP (hemolysis, elevated liver enzyme and low platelets) syndrome was investigated, and the following results were obtained. (1) The plasma concentration of hHGF in pregnant women did not change with the gestational stage. (2) The plasma concentration of hHGF in pregnant women with EPH (edema, proteinuria and hypertension) gestosis was 0.19 ± 0.07 ng/ml and did not differ greatly from that in control pregnant women. (3) The plasma concentration of hHGF in pregnant women with HELLP syndrome was 1.79 ± 0.35 ng/ml; it was increased prominently compared to control pregnant women. (4) The plasma concentration of hHGF in pregnant women with HELLP syndrome changed parallel to the clinical symptoms of the syndrom
点击下载:
PDF
(1249KB)
返 回